Gain Therapeutics, Inc.
GANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819411
No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Gain Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 42 | 50 | +8 |
| Shares | 8.19M | 8.66M | +465.8K (+5.7%) |
| Value | $15.8M | $17.4M | +$1.57M (+9.9%) |
New holders (12)
Institutions that held Gain Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 136,359 | $276.8K | 0.00% |
| XTX Topco Ltd | 55,294 | $112.2K | 0.00% |
| HighTower Advisors, LLC | 17,174 | $34.9K | 0.00% |
| HB Wealth Management, LLC | 12,783 | $25.9K | 0.00% |
| Two Sigma Securities, LLC | 12,739 | $25.9K | 0.00% |
| Harbour Investments, Inc. | 10,745 | $21.8K | 0.00% |
| Mercer Global Advisors Inc | 10,000 | $20.3K | 0.00% |
| Sanctuary Advisors, LLC | 10,000 | $20.3K | 0.00% |
| Advisor Group Holdings, Inc. | 2,000 | $4.06K | 0.00% |
| SRS Capital Advisors, Inc. | 1,700 | $3.45K | 0.00% |
| Barclays PLC | 1,352 | $2.75K | 0.00% |
| Caitong International Asset Management Co., Ltd | 165 | $335 | 0.00% |
Sold out (4)
Institutions that held Gain Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 24,500 | $47.5K |
| Simplex Trading, LLC | 13,439 | $26.1K |
| Kestra Advisory Services, LLC | 12,000 | $23.3K |
| Citigroup Inc | 1 | $2 |